Total Payments
$192,120
2024 Payments
$16,303
Companies
50
Transactions
808
Medicare Patients
5,306
Medicare Billing
$410,663
Payment Breakdown by Category
Other$145,018 (75.5%)
Food & Beverage$19,324 (10.1%)
Consulting$13,581 (7.1%)
Travel$12,915 (6.7%)
Education$1,283 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $145,018 | 79 | 75.5% |
| Food and Beverage | $19,324 | 641 | 10.1% |
| Consulting Fee | $13,581 | 19 | 7.1% |
| Travel and Lodging | $12,915 | 52 | 6.7% |
| Education | $1,283 | 17 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avadel Specialty Pharmaceuticals, LLC | $60,152 | 64 | $0 (2019) |
| Allergan, Inc. | $28,311 | 83 | $0 (2022) |
| ABBVIE INC. | $21,206 | 82 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $17,165 | 23 | $0 (2023) |
| UROVANT SCIENCES INC | $16,794 | 25 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $14,072 | 35 | $0 (2024) |
| Astellas Pharma US Inc | $13,797 | 75 | $0 (2024) |
| Boston Scientific Corporation | $7,111 | 36 | $0 (2023) |
| Laborie Medical Technologies Corp. | $3,074 | 3 | $0 (2018) |
| Medline Industries, Inc. | $2,050 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,303 | 92 | ABBVIE INC. ($9,214) |
| 2023 | $20,659 | 103 | Sumitomo Pharma America, Inc. ($9,817) |
| 2022 | $15,987 | 97 | UROVANT SCIENCES INC ($7,404) |
| 2021 | $18,336 | 71 | UROVANT SCIENCES INC ($9,391) |
| 2020 | $23,228 | 81 | Bayer HealthCare Pharmaceuticals Inc. ($10,568) |
| 2019 | $14,993 | 127 | Astellas Pharma US Inc ($7,046) |
| 2018 | $71,549 | 148 | Avadel Specialty Pharmaceuticals, LLC ($60,114) |
| 2017 | $11,066 | 89 | Allergan Inc. ($9,931) |
All Payment Transactions
808 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $129.66 | General |
| Category: Urology | ||||||
| 12/17/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $24.61 | General |
| 12/13/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Urology Gynecology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/13/2024 | Caldera Medical, Inc | Desara (Device) | Food and Beverage | Cash or cash equivalent | $188.66 | General |
| Category: Urogynaecology | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: UROLOGY | ||||||
| 10/20/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $17.19 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $107.46 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: UROLOGY | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/10/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $105.92 | General |
| Category: Women's Health | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Urology Gynecology | ||||||
| 09/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/30/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Urology | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: HORMONE THERAPY | ||||||
| 08/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,207 | 8,308 | $258,783 | $106,160 |
| 2022 | 14 | 1,356 | 9,185 | $264,547 | $113,120 |
| 2021 | 15 | 1,314 | 6,928 | $217,633 | $94,587 |
| 2020 | 15 | 1,429 | 6,933 | $254,851 | $96,796 |
Total Patients
5,306
Total Services
31,354
Medicare Billing
$410,663
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 23 | 6,850 | $68,500 | $33,341 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 259 | 286 | $50,170 | $18,242 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 205 | $47,986 | $18,063 | 37.6% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 24 | 45 | $27,405 | $13,676 | 49.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 54 | $16,740 | $5,497 | 32.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 25 | 33 | $10,593 | $5,456 | 51.5% |
| 51715 | Injection of implant material beneath lining of bladder and/or urethra using an endoscope | Facility | 2023 | 14 | 17 | $9,707 | $2,543 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $5,830 | $2,402 | 41.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 411 | 555 | $4,440 | $1,872 | 42.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 29 | $4,350 | $1,797 | 41.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 156 | 188 | $6,956 | $1,439 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,771 | $1,249 | 26.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 15 | $1,335 | $581.70 | 43.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 27 | 7,450 | $74,000 | $35,947 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 226 | 265 | $56,586 | $23,133 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 296 | $45,092 | $18,640 | 41.3% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2022 | 27 | 47 | $28,623 | $14,816 | 51.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 20 | 28 | $8,988 | $4,786 | 53.2% |
| 51715 | Injection of implant material beneath lining of bladder and/or urethra using an endoscope | Facility | 2022 | 18 | 19 | $10,849 | $2,665 | 24.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 491 | 749 | $5,992 | $2,550 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,096 | $1,916 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $4,063 | $1,747 | 43.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 198 | 230 | $8,510 | $1,640 | 19.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $4,002 | $1,415 | 35.4% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,828 | $1,299 | 33.9% |
About Dr. Brian Murray, MD
Dr. Brian Murray, MD is a Urology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083659072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Murray, MD has received a total of $192,120 in payments from pharmaceutical and medical device companies, with $16,303 received in 2024. These payments were reported across 808 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($145,018).
As a Medicare-enrolled provider, Murray has provided services to 5,306 Medicare beneficiaries, totaling 31,354 services with total Medicare billing of $410,663. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Albany, NY
- Active Since 06/17/2006
- Last Updated 05/19/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1083659072
Products in Payments
- Noctiva (Drug) $60,152
- BOTOX (Biological) $34,694
- GEMTESA (Drug) $30,638
- MYRBETRIQ (Drug) $11,813
- Nubeqa (Drug) $10,002
- Xofigo (Drug) $7,163
- BOTOX (Drug) $6,399
- BOTOX THERAPEUTIC - HH (Biological) $6,019
- GENERAL - THERAPIES (Device) $5,106
- Dermatology and Wound Care (Medical Supply) $2,025
- INTERSTIM (Device) $1,428
- Desara (Device) $1,266
- XTANDI (Drug) $789.16
- BOTOX - UROLOGY (Drug) $749.94
- BOTOX OAB (Drug) $482.10
- Altis (Device) $423.78
- Advantage System (Device) $410.00
- Erleada (Drug) $403.91
- Solyx SIS System (Device) $394.27
- Axonics (Device) $378.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Albany
Ronald Kaufman
Urology — Payments: $254,854
Urology $254,854
Dr. Brian Inouye, M.d, M.D
Urology — Payments: $51,447
Urology $51,447
Elise De, Md, MD
Urology — Payments: $22,035
Urology $22,035
Dr. Robert Welliver, Md, MD
Urology — Payments: $21,369
Urology $21,369
Dr. Michael Monahan, D.o, D.O
Urology — Payments: $20,147
Urology $20,147
Khaled Ajib, Md, MD
Urology — Payments: $14,088
Urology $14,088